Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Other Non-Current Assets: 2011-2024

Historic Other Non-Current Assets for Mimedx Group (MDXG) over the last 12 years, with Dec 2024 value amounting to $1.1 million.

  • Mimedx Group's Other Non-Current Assets rose 153.14% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 153.14%. This contributed to the annual value of $1.1 million for FY2024, which is 439.51% up from last year.
  • Per Mimedx Group's latest filing, its Other Non-Current Assets stood at $1.1 million for FY2024, which was up 439.51% from $205,000 recorded in FY2023.
  • Over the past 5 years, Mimedx Group's Other Non-Current Assets peaked at $1.9 million during FY2022, and registered a low of $186,000 during FY2021.
  • For the 3-year period, Mimedx Group's Other Non-Current Assets averaged around $1.1 million, with its median value being $1.1 million (2024).
  • In the last 5 years, Mimedx Group's Other Non-Current Assets spiked by 903.23% in 2022 and then slumped by 89.01% in 2023.
  • Yearly analysis of 5 years shows Mimedx Group's Other Non-Current Assets stood at $375,000 in 2020, then tumbled by 50.40% to $186,000 in 2021, then spiked by 903.23% to $1.9 million in 2022, then crashed by 89.01% to $205,000 in 2023, then spiked by 439.51% to $1.1 million in 2024.